Login to Your Account



Other News To Note


Monday, October 29, 2012
• Pharmaxis Ltd., of Sydney, Australia, said the National Institute for Health and Clinical Excellence in the UK issued a positive recommendation in its final appraisal determination for Bronchitol (mannitol dry powder for inhalation), approved to treat adult cystic fibrosis patients as an add-on therapy to best standard of care.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription